Natixis Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.14M | Buy |
117,934
+21,396
| +22% | +$1.11M | 0.01% | 778 |
|
|
2025
Q1 | $5.83M | Sell |
96,538
-26,012
| -21% | -$1.57M | 0.01% | 774 |
|
|
2024
Q4 | $8.39M | Buy |
122,550
+11,641
| +10% | +$797K | 0.02% | 703 |
|
|
2024
Q3 | $7.98M | Buy |
110,909
+29,720
| +37% | +$2.14M | 0.02% | 710 |
|
|
2024
Q2 | $5.63M | Buy |
81,189
+34,744
| +75% | +$2.41M | 0.01% | 761 |
|
|
2024
Q1 | $3.72M | Sell |
46,445
-6,136
| -12% | -$491K | 0.01% | 874 |
|
|
2023
Q4 | $5.76M | Buy |
52,581
+8,634
| +20% | +$945K | 0.02% | 713 |
|
|
2023
Q3 | $4.43M | Buy |
43,947
+5,506
| +14% | +$555K | 0.01% | 748 |
|
|
2023
Q2 | $5.22M | Buy |
38,441
+3,352
| +10% | +$456K | 0.02% | 687 |
|
|
2023
Q1 | $3.64M | Buy |
35,089
+11,084
| +46% | +$1.15M | 0.01% | 781 |
|
|
2022
Q4 | $2.13M | Buy |
24,005
+8,006
| +50% | +$710K | 0.01% | 924 |
|
|
2022
Q3 | $1.28M | Buy |
+15,999
| New | +$1.28M | 0.01% | 1028 |
|